I guarantee you this news will make your professional life a whole lot easier and even more gratifying.
All over the world, vascular access specialists are now using ultrasound to help insert peripheral IVs (PIVs). Because of this, central line insertions are often avoided and existing central lines are able to be discontinued. That’s the good news.
The bad news is: the median dwell time of ultrasound guided PIVs is 26 hours, and their failure rate is nearly 50%. Ultrasound-guided PIVs just cannot last, they are too short and made of the wrong material (i.e. polyurethane).
Fortunately, Access Scientific has the solution—POWERWAND™ EDC: The first power-injectable, non-trimmable 6cm extended-dwell, 3Fr catheter, specifically designed for ultrasound-guided peripheral IV access. Like all POWERWANDs, the EDC is made of ChronoFlex™C and inserted using either the XL method (easiest) or the accelerated Seldinger technique (fastest).
Does it perform? Preliminary data from a prestigious urban hospital—currently in the process of publishing these remarkable results—revealed the POWERWAND™ EDC average dwell time of 11.2 days. That’s longer than the vast majority of midlines! And, the POWERWAND™ EDC resulted in a 39.1% reduction of central line usage. No other peripheral IV in the world can boast such extraordinary results.
Imagine not having to go back again and again to the same patient to start and restart an ultrasound-guided PIV. Imagine not having to ultimately start a PICC or CVC and risk a CLABSI on that poor patient. Imagine the patient and family sincerely offering you their thanks.
There is a new and better tool in your toolbox—the revolutionary 6cm, 3Fr POWERWAND™ EDC. I’m sure if you try it, you’ll quickly realize it is by far the best peripheral vascular access device ever made.
Steve Bierman MD
Definitive proof has finally arrived. PICCs are no longer required to deliver long-term or short-term vancomycin (4mg/ml). Over 1000 patients, representing over 8000 catheter-days, are reported in this month’s JAVA to have had no DVTs and no bloodstream infections and minimal phlebitis (0.6%) during intravenous vancomycin administration through the POWERWAND midline. (Full article)
What does this groundbreaking study mean for you and your institution?
In most hospitals, vancomycin administration is an indication for about 20% of PICCs. This new POWERWAND study demonstrates that these patients no longer need PICCs, which means you can reduce your central line days by roughly 20%. Instead of a PICC, a 4Fr or 5Fr POWERWAND placed in the deep vessels of the upper arm will get the job done safer and more cost-efficiently. In fact, placing a POWERWAND is usually at least $90.00 less expensive than placing a PICC.
Remember, only the POWERWAND midline has over 20,000 catheter days of published data attesting to zero bloodstream infections and the lowest complication rates of any vascular access device ever studied. (refs) Couple this with the news of safe vancomycin administration (over 5 years, in over 1000 patients) and you really have compelling reasons to support your POWERWAND use.
It’s a pleasure to share this information with you, because it means that everyone—patients and providers—gets to share the benefits POWERWAND use. Thank you for your continued, evidence-based support.
Steve Bierman, MD
Chief Medical Officer
I often travel to hospitals all over the country and hear stories from clinicians who are frustrated by peripheral IVs that don’t last. Think about your own practice – how often does it happen that you are called to start a peripheral IV on a hard stick patient only to have to restart it the next day?
Did you know that the median dwell time for an ultrasound-guided PIV is only 26 hours? All the skill, time and effort you and your colleagues apply to the placement of these vital lines, unfortunately, results in an IV that lasts barely more than a day. Why? Because PIVs are simply too short (and too easily kinked) to function for any substantial time in the deeper veins of the arm and forearm.
Fortunately, there is a solution: The first true extended dwell catheter designed to extend the life of ultrasound guided peripheral IVs up to 29 days – The new POWERWAND™ EDC–3French, 6 cm (2.4 inches).
The new 3Fr, 6 cm POWERWAND is longer than a PIV, capable of power-injection up to 8 mL/sec, and is designed for the same reliable blood-drawability and extended dwell times as the POWERWAND midlines. Made of ChronoFlex™C, this new tool in your toolbox, is ideal for renal patients–and vein preservation, in general; ultrasound guided PIVs, patient’s requiring extended treatment but who do not need the hemodilution afforded by the POWERWAND midlines.
Please consider this next great innovation from Access Scientific–the POWERWAND 3Fr, 6cm Extended Dwell Catheter. Your patients will thank you.
Steve Bierman, MD
Chief Medical Officer